Andere Kunden interessierten sich auch für
![Targeting Oncogenic Driver Mutations in Lung Cancer]( "Targeting Oncogenic Driver Mutations in Lung Cancer")
Targeting Oncogenic Driver Mutations in Lung Cancer23,99 €![Prostate Cancer Imaging and Therapy, an Issue of Pet Clinics]( "Prostate Cancer Imaging and Therapy, an Issue of Pet Clinics")
Prostate Cancer Imaging and Therapy, an Issue of Pet Clinics65,99 €![Therapeutic Targeting of Ras Mutant Cancers]( "Therapeutic Targeting of Ras Mutant Cancers")
Therapeutic Targeting of Ras Mutant Cancers25,99 €![Personalized Drug Screening for Functional Tumor Profiling]( "Personalized Drug Screening for Functional Tumor Profiling")
Personalized Drug Screening for Functional Tumor Profiling25,99 €![Overcoming Resistance to Egfr Inhibitors in Egfr-Mutant Nsclc]( "Overcoming Resistance to Egfr Inhibitors in Egfr-Mutant Nsclc")
Overcoming Resistance to Egfr Inhibitors in Egfr-Mutant Nsclc143,99 €![Human Herpesviruses Hhv-6a, Hhv-6b and Hhv-7]( "Human Herpesviruses Hhv-6a, Hhv-6b and Hhv-7")
Human Herpesviruses Hhv-6a, Hhv-6b and Hhv-788,99 €![Drug Resistance in the Treatment of Cancer]( "Drug Resistance in the Treatment of Cancer")
Drug Resistance in the Treatment of Cancer106,99 €
This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations.